Item 2.02 Results of Operations and Financial Condition.
On November 1, 2022, ABIOMED, Inc. (the "Company," "we" or "us") issued a press
release reporting our financial results for our second quarter ended September
30, 2022. A copy of the press release is set forth as Exhibit 99.1 and is
incorporated herein by reference. The information contained in this report shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934 or otherwise subject to the liabilities of that Section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933
or the Securities Exchange Act of 1934, whether made before or after the date
hereof and regardless of any general incorporation language in such filing,
except as expressly set forth by specific reference in such filing.
Caution Concerning Forward-Looking Statements
This Form 8-K contains information that includes or is based on forward-looking
statements within the meaning of the federal securities laws that are subject to
various risks and uncertainties that could cause our actual results to differ
materially from those expressed or implied in such statements. Such statements
include, but are not limited to, those regarding our financial performance and
the impact of the COVID-19 pandemic on our operations and financial results and
are subject to, among other risks, the COVID-19 pandemic and any related
policies and actions by governments or other third parties. Additional
information concerning these and other factors is contained in our filings with
the U.S. Securities and Exchange Commission, including our Annual Report on Form
10-K and Quarterly Reports on Form 10-Q that we have filed or will file
hereafter. We disclaim any intention or obligation to publicly update or revise
any forward-looking statement to reflect any change in our expectations or in
events, conditions or circumstances on which those expectations may be based, or
that affect the likelihood that actual results will differ from those contained
in the forward-looking statements.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Description
99.1 Press release dated November 1, 2022
104 Cover Page Interactive Data File (embedded with the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses